Search Results 81-90 of 28143 for B cell lymphomas

  1. Compare the Efficacy and Safety of Golcadomide Plus R-CHOP vs Placebo Plus RCHOP in Participants with Previously Untreated High-risk Large B-cell Lymphoma - Mayo Clinic

    Compare the Efficacy and Safety of Golcadomide Plus R-CHOP vs Placebo Plus RCHOP in Participants with Previously Untreated High-risk Large B-cell Lymphoma.

  2. Study of Lenzilumab and Axicabtagene Ciloleucel in Subjects with Relapsed or Refractory Large B-cell Lymphoma - Mayo Clinic

    Study of Lenzilumab and Axicabtagene Ciloleucel in Subjects with Relapsed or Refractory Large B-cell Lymphoma · Overview · Participation eligibility.

  3. Doctors and departments - Mayo Clinic

    Research. Mayo Clinic doctors and researchers are studying diffuse large B-cell lymphoma to look for new ways to improve diagnosis and treatment for this ...

  4. A Study Evaluating The Effectiveness And Safety Of Axicabtagene Ciloleucel In Subjects With High-Risk Large B-Cell Lymphoma - Mayo Clinic

    A Study Evaluating The Effectiveness And Safety Of Axicabtagene Ciloleucel In Subjects With High-Risk Large B-Cell Lymphoma · More about research at Mayo Clinic.

  5. DNA Sequencing-Based Monitoring Of Minimal Residual Disease To Predict Relapse In Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

    DNA Sequencing-Based Monitoring Of Minimal Residual Disease To Predict Relapse In Aggressive B-cell Non-Hodgkin Lymphomas · Share · Facebook · Twitter.

  6. Lymphoma - Doctors and departments - Mayo Clinic

    Developing the first genetic test to help guide the diagnosis and treatment of people with diffuse large B-cell lymphoma, the most common type of non-Hodgkin ...

  7. A Study Of JNJ-90014496 In Participants With B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    ... B-Cell non-Hodgkin lymphoma (B-NHL) or frontline high-risk diffuse large B-cell lymphoma (DLBCL). Participation eligibility. Participant eligibility includes ...

  8. A Study To Evaluate Brentuximab Vedotin Or Placebo In Combination With Lenalidomide And Rituximab In Subjects With Relapsed Or Refractory Diffuse Large B-cell Lymphoma (DLBCL) - Mayo Clinic

    ... B-cell lymphoma (DLBCL). Participants in this study will have Diffuse Large B-cell Lymphoma (DLBCL) that has come back or not gotten better with treatment.

  9. A Study Of The Effectiveness And Safety Of CTL019 In Adult Patients With Diffuse Large B-Cell Lymphoma - Mayo Clinic

    The purpose of this study is to determine the efficacy and safety of CTL019 in adult patients with relapsed or resistant diffuse large B-cell lymphoma.

  10. A Study To Compare The Effectiveness And Safety Of JCAR017 To Standard Of Care In Adult Subjects With High-risk, Transplant-eligible Relapsed Or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

    ... B-cell Non-Hodgkin Lymphomas. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information ...